You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Figure GPS-33:  Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) – Part (i) Cannabis use – lifetime experience, recent use (last 12 months) and current use (last 30 days)

Figure GPS-33 part i

Notes:

For details of the studies included see Table GPS-1 to Table GPS-6.

The chart shows the overall average of the relevant studies, weighted by sample size.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Reitox national reports (2005), taken from population surveys, reports or scientific articles.

See also Table GPS-0.